Ultima Vez Modificado: 26 de agosto del 2004
Conference Dates: September 22, 2004
Conference Location: Telephone Conference
Sponsoring Group: National Marrow Donor Program, CancerCare and The Leukemia & Lymphoma Society
Conference Web Page URL: www.marrow.org/NEWS/EVENTS/aml_workshop.html
Topics Covered: An overview of acute myelogenous leukemia (AML), by Dr. Selina Luger An overview of AML treatment options, including marrow and blood stem cell transplantation, by Dr. Douglas Rizzo.
Conference Objectives: Provide an overview for patients on treatment options for AML, including marrow and blood cell transplantation
Who Should Attend: Patients
Conference Fees: Free
Continuing Education: NoEnglish
Dec 8, 2010 - Individuals who donate peripheral blood stem cells or bone marrow do not appear to be at an overall increased risk of cancer, according to research being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. According to another study, acute myeloid or lymphoblastic leukemia patients who receive double unrelated cord blood transplants may experience better overall outcomes than those who receive single cord blood transplants. Other studies being presented address stem cell transplant procedures in treating various hematologic malignancies and highlight zoledronic acid's ability to improve survival in multiple myeloma patients.
Dec 8, 2010
Feb 2, 2010
Aug 28, 2014
Aug 28, 2014